Covid-19 vaccinesrare adverse eventsSARS-CoV-2vaccine efficacyvariants of concernSince the outbreak of coronavirus disease 2019 (Covid-19) in December 2019, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the number of confirmed infections has risen to more than 242...
Tracking SARS-CoV-2variants. (n.d.). Retrieved June6, 2021, fromhttps://www.who.int/activities/tracking-SARS-CoV-2-variants Ad, J. (n.d.). Vaccinesand Related Biological Products Advisory Committee Meeting February 26, 202.62. Al Kaabi, N., Zhang, Y., Xia,S., Yang, Y., Al Qaht...
[02:11.36]In February, the head of Britain’s vaccination effort [02:15.80]said the world faced around 4,000 variants [02:20.84]of the virus that causes COVID-19. [02:25.04]But only some would raise concern. [...
Two major variants of the virus that causes COVID-19 have emerged in recent weeks, raising questions about their contagiousness and accuracy of testing – but neither is more dangerous than the virus that has circulated for the last year, experts say, and available vaccines should remain effectiv...
Are COVID-19 vaccines effective against new variants of concern of the SARS-CoV-2 virus? 4:07 min Why do immunocompromised people need an additional dose of COVID-19 vaccines? 1:05 min Why are some vaccinated people getting sick with COVID-19 and in some cases being hospitalized?
[11] Rosenblum HG, Wallace M, Godfrey M, et al. Interim recommendations from the advisory committee on immunization practices for the use of bivalent booster doses of COVID-19 vaccines—United States, October 2022. MMWR Morb Mortal Wkly Rep 2022; 71: 1436–41. ...
Current COVID-19 vaccines are based on the SARS-CoV-2 spike protein, which the virus uses to bind to and infect host cells, of the original Wuhan-hu-1. But the emerging “variants of concern”—deemed so because they appear to be more transmissible or deadlier than the wild-type SARS-...
It's important to keep in mind that vaccines such as the ones developed by Moderna and Pfizer remain extremely effective against severe disease caused by SARS-CoV-2— variants and all.要知道，像莫德纳和辉瑞公司开发的疫苗对SARS-CoV-2变异引起的重症仍然非常有效。And early results investigating their...
Mallapaty, S. (2021). China’ScoVID vaccines are going global—But questions remain. Nature, 593(7858),178–179. https://doi.org/10.1038/d41586-021-01146-0 Moderna AnnouncesPositive Initial Booster Data Against SARS-CoV-2 Variants of Concern | Moderna,Inc. (n.d.).Retrieved June 6, ...
Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and associated mortality than the general population. Owing to this increased risk, patients with cancer have been prioritized for COVID-19 vaccination globally, for both primary and booster vaccinations. However, given...